VRNA Form 4: RSUs and Options Converted to $107 per ADS Cash
Rhea-AI Filing Summary
Director Michael Austwick reported transactions tied to a company sale: at the 10/07/2025 effective time of a Scheme of Arrangement, outstanding time‑based restricted share units and in‑the‑money options were accelerated and converted into cash. Each American Depositary Share represented eight Ordinary Shares and received $107 in cash per ADS (equivalent to $13.375 per Ordinary Share). The filing shows a disposition of 12,712 Ordinary Shares and the vesting/conversion of awards equal to 72,000 Ordinary Shares (RSUs) and 144,000 underlying Ordinary Shares from share options, leaving 72,000 ADS-equivalent shares reported as beneficially owned following the RSU conversion.
Positive
- Cash consideration of $107 per ADS paid to holders at the Effective Time
- RSUs accelerated and cashed, converting 72,000 ADS-equivalent Ordinary Shares into cash
- In‑the‑money options settled for cash under the agreement, crystallizing value for the reporting person
Negative
- Director’s direct ownership reduced to zero for certain share classes after the transaction
- Disposition of 12,712 Ordinary Shares reported, representing a reduction in reported holdings
Insights
Director holdings were largely cashed out under the takeover terms; awards accelerated and converted to cash.
The transaction reflects a corporate control event where outstanding equity awards (RSUs and options) were accelerated and converted into cash based on an agreed ADS consideration of $107 per ADS at the 10/07/2025 effective time. The filing records both dispositions and cash settlement mechanics rather than open-market trades.
Key dependencies include the Scheme of Arrangement and the Transaction Agreement terms that determined vesting acceleration and cash conversion. Monitor any post-closing disclosures on residual beneficial ownership or supplemental consideration in the near term.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Share Unit | 72,000 | $0.00 | -- |
| Disposition | Share Options (Right to Buy) | 144,000 | $0.00 | -- |
| Disposition | Ordinary Shares | 12,712 | $0.00 | -- |
| Exercise | Ordinary Shares | 72,000 | $0.00 | -- |
| Disposition | Ordinary Shares | 72,000 | $0.00 | -- |
Footnotes (1)
- Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer. Represents Ordinary Shares of the Issuer acquired from the Reporting Person by means of a scheme of arrangement (the "Scheme of Arrangement") under Part 26 of the UK Companies Act 2006, pursuant to a transaction agreement, dated as of July 8, 2025 (the "Transaction Agreement"), by and among the Issuer, Merck Sharp & Dohme LLC, a New Jersey limited liability company ("Parent") and Vol Holdings LLC, a Delaware limited liability company and wholly owned subsidiary of Parent ("Bidco"). At the effective time of the Scheme of Arrangement (the "Effective Time"), each holder of the Scheme Shares (as defined in the Scheme of Arrangement) became entitled to receive $13.375 in cash per Scheme Share, without interest and net of any applicable withholding taxes. Because each ADS represents a beneficial ownership interest in eight (8) Ordinary Shares of the Issuer, holders of ADSs as of the Effective Time became entitled to receive eight (8) times the foregoing cash amount, or $107 in cash, without interest and net of any applicable withholding taxes, per ADS (the "ADS Consideration"). Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award ("RSU Award"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration. Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date. Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding share option became fully vested, to the extent unvested, and at the Effective Time, each share option that had an exercise price less than the ADS Consideration was automatically converted into the right to receive an amount in cash equal to the product of (i) the aggregate number of ADSs underlying such share option and (ii) the excess, if any, of (a) an amount equal to the ADS Consideration over (b) the exercise price of such share option.
